Literature DB >> 12134363

Clinical oncologic positron emission tomography: an introduction.

Timothy G Turkington1, R Edward Coleman.   

Abstract

PET imaging is a molecular imaging technology that is diffusing into imaging departments quite rapidly. The unique characteristics of positron emitting radionuclides such as fluorine-18 provide high-quality images with reasonable acquisition times. The imaging instrumentation continues to improve with new detector materials and combinations of PET scanners and CT scanners. FDG is now readily available to most hospitals in the United States. Third-party payers now recognize the importance of PET imaging in multiple malignancies. The number of PET scans performed annually will continue to increase as the indications increase and the instrumentation is more available.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12134363     DOI: 10.1016/s0037-198x(02)80029-3

Source DB:  PubMed          Journal:  Semin Roentgenol        ISSN: 0037-198X            Impact factor:   0.800


  4 in total

1.  Sarcoidosis mimicking metastatic progression of pancreatic neuroendocrine tumor: A case report.

Authors:  Ivan Lolli; Elisa Stasi; Fabio Fucilli; Michele Pirrelli; Raffaele Armentano; Giovanna Campanella; Claudio Lotesoriere; Dionigi Lorusso
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

2.  PET/CT-negative malignant spine tumor with pathologic fracture: A case report of malignant solitary bone plasmacytoma.

Authors:  Kang-Un Kim; Joon Hyuk Choi; Gun Woo Lee
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

3.  PET and CT features differentiating infectious/inflammatory from malignant mediastinal lymphadenopathy: A correlated study with endobronchial ultrasound-guided transbronchial needle aspiration.

Authors:  Haiyan Wang; Qing Kay Li; Martin Auster; Gary Gong
Journal:  Radiol Infect Dis       Date:  2018-02-01

Review 4.  False positive and false negative FDG-PET scans in various thoracic diseases.

Authors:  Jung Min Chang; Hyun Ju Lee; Jin Mo Goo; Ho-Young Lee; Jong Jin Lee; June-Key Chung; Jung-Gi Im
Journal:  Korean J Radiol       Date:  2006 Jan-Mar       Impact factor: 3.500

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.